CONTRACTUAL
For R&D and Translational Medicine executives: we can help you run your programs better, faster, cheaper and safer
With CADI™ Discovery, BMSystems possesses a truly unique competitive advantage: the ability to address and exploit the two major issues in life sciences that are:
-
the enormous complexity of life’s mechanisms, and
-
the significant and growing unreliability of scientific and clinical publications.
BMSystems generates directly exploitable solutions for:
Physiological/ Diseases Mechanisms Understanding
Multi-systems mechanisms
Exploratory Discovery program to discover novel causal mechanisms concepts
Novel hypotheses for therapeutic and/or diagnostic solutions discovery
Targets Discovery & Validation
Discovery & validation of biomarker’s signatures
New Therapeutic/ Diagnostic/ Cosmetics Strategies
Molecules mechanisms of action
New associations of molecules & devices
New associations of existing molecules
R&D/ Molecules /Clinical Programs Evaluation
GO/NO GO decision before product acquisition or for portfolio risk analysis
Next Phase GO/NO GO decision
R&D program Rescue for a program facing critical issues during its lifetime
External R&D “plan B” program when the “A plan” cannot be rescued
Drug (re) positioning /(re) profiling
Drug side effects analysis for rescue
BMSystems has successfully completed contractual projects in the following areas:
-
Immunology of Infectious & Inflammatory Diseases
-
Immune & Metabolic Interactions
-
Drug mechanisms in the context of Autism Spectrum Disorders
-
Creutzfeld-Jacobs Disease
-
Integrins Dependent Metastasis Mechanisms
-
Neuropathic Pains/ Chronic Pains/ Nociception Mechanisms
-
Skin Homeostasis
-
Cardiovascular Diseases
-
Synthons Production/ Industrial Biotechnology
For additional information, you are welcome to visit our successfully completed CADI™ programs and our therapeutic projects page.